[Retracted] Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Figure 2

Violin plots show the expression of CDCA3 in different stages of various tumors. (a) ACC, (b) BRCA, (c) KICH, (d) KIRC, (e) KIRP, (f) LIHC, (g) LUAD, and (h) TGCT.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)